Added IMPACT: The first successful natural birth using certolizumab in obstetric APS

Anastasia Madenidou; Hannah Kither; Sarah Dyball; Ian Bruce; Clare Tower

doi:10.1016/j.thromres.2024.109088

Added IMPACT: The first successful natural birth using certolizumab in obstetric APS

Anastasia Madenidou, Hannah Kither, Sarah Dyball, Ian Bruce, Clare Tower

Research output: Contribution to journal › Letter › peer-review

48 Downloads (Pure)

Original language	English
Article number	109088
Journal	Thrombosis Research
Volume	241
Early online date	3 Jul 2024
DOIs	https://doi.org/10.1016/j.thromres.2024.109088
Publication status	Published - 1 Sept 2024

Keywords

Anti-phospholipid syndrome
Obstetric APS
Pregnancy
Anti-TNF
Certolizumab

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.thromres.2024.109088

APS letter acceptedAccepted author manuscript, 29.2 KBLicence: CC BY
Figure 1Licence: CC BY

Cite this

@article{b85aa66625574e3087065d0c3068dd87,

title = "Added IMPACT: The first successful natural birth using certolizumab in obstetric APS",

keywords = "Anti-phospholipid syndrome, Obstetric APS, Pregnancy, Anti-TNF, Certolizumab",

author = "Anastasia Madenidou and Hannah Kither and Sarah Dyball and Ian Bruce and Clare Tower",

year = "2024",

month = sep,

day = "1",

doi = "10.1016/j.thromres.2024.109088",

language = "English",

volume = "241",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Added IMPACT: The first successful natural birth using certolizumab in obstetric APS

AU - Madenidou, Anastasia

AU - Kither, Hannah

AU - Dyball, Sarah

AU - Bruce, Ian

AU - Tower, Clare

PY - 2024/9/1

Y1 - 2024/9/1

KW - Anti-phospholipid syndrome

KW - Obstetric APS

KW - Pregnancy

KW - Anti-TNF

KW - Certolizumab

UR - https://www.scopus.com/pages/publications/85197567630

U2 - 10.1016/j.thromres.2024.109088

DO - 10.1016/j.thromres.2024.109088

M3 - Letter

SN - 0049-3848

VL - 241

JO - Thrombosis Research

JF - Thrombosis Research

M1 - 109088

ER -

Added IMPACT: The first successful natural birth using certolizumab in obstetric APS

Keywords

UN SDGs

Access to Document

Other files and links

Cite this